Charles Schwab’s ASP Isotopes ASPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.01M Buy
1,134,234
+198,882
+21% +$791K ﹤0.01% 2683
2026
Q2
$5.82M Buy
935,352
+38,116
+4% +$224K ﹤0.01% 2404
2026
Q1
$3.97M Buy
897,236
+11,497
+1% +$68K ﹤0.01% 2494
2025
Q4
$4.74M Buy
885,739
+223,778
+34% +$1.78M ﹤0.01% 2478
2025
Q3
$6.37M Buy
661,961
+487,033
+278% +$4.49M ﹤0.01% 2322
2025
Q2
$1.29M Buy
174,928
+9,564
+6% +$64.1K ﹤0.01% 2821
2025
Q1
$776K Buy
165,364
+7,138
+5% +$35.6K ﹤0.01% 2932
2024
Q4
$717K Buy
158,226
+37,948
+32% +$202K ﹤0.01% 3029
2024
Q3
$334K Buy
120,278
+17,159
+17% +$45.6K ﹤0.01% 3265
2024
Q2
$316K Buy
+103,119
New +$398K ﹤0.01% 3357

Other funds holding ASPI

Charles Schwab's ASPI Position: Q3 2026 in Review

Charles Schwab increased its ASP Isotopes (ASPI) stake by 21% in Q3 2026, buying an estimated $791K and bringing the position to 1,134,234 shares worth $3.01M. The position accounts for ﹤0.01% of the portfolio, ranked #2683.

Charles Schwab first reported a position in ASPI in Q2 2024 and has held it in 10 quarters since. The position peaked at $6.37M in Q3 2025. 158 funds tracked by Wall St. Rank hold ASPI as of Q3 2026.

  • Charles Schwab held 1,134,234 shares of ASP Isotopes worth $3.01M as of Q3 2026.
  • Charles Schwab bought 198,882 ASP Isotopes shares in Q3 2026, an estimated $791K.
  • ASP Isotopes made up ﹤0.01% of Charles Schwab's portfolio in Q3 2026, its #2683 holding.
  • Charles Schwab first reported a position in ASP Isotopes in Q2 2024 and has held it in 10 quarters since.
  • Charles Schwab's ASP Isotopes position peaked at $6.37M in Q3 2025.
  • 158 funds tracked by Wall St. Rank held ASP Isotopes as of Q3 2026.

Based on Charles Schwab's 13F filing for Q3 2026, filed 16 Nov 2026.